Ackland SP - Search Results

1

Human plasma pharmacokinetics of thiotepa following administration of high-dose thiotepa and cyclophosphamide.

Ackland SP, Choi KE, Ratain MJ, Egorin MJ, Williams SF, Sinkule JA, Bitran JD. Ackland SP, et al. J Clin Oncol. 1988 Jul;6(7):1192-6. doi: 10.1200/JCO.1988.6.7.1192. J Clin Oncol. 1988. PMID: 3134519

2

Pharmacokinetics and pharmacodynamics of long-term continuous-infusion doxorubicin.

Ackland SP, Ratain MJ, Vogelzang NJ, Choi KE, Ruane M, Sinkule JA. Ackland SP, et al. Clin Pharmacol Ther. 1989 Apr;45(4):340-7. doi: 10.1038/clpt.1989.39. Clin Pharmacol Ther. 1989. PMID: 2702792

3

High-dose methotrexate: a critical reappraisal.

Ackland SP, Schilsky RL. Ackland SP, et al. J Clin Oncol. 1987 Dec;5(12):2017-31. doi: 10.1200/JCO.1987.5.12.2017. J Clin Oncol. 1987. PMID: 3316519 Review.

4

Management of locally advanced and inflammatory carcinoma of the breast.

Ackland SP, Bitran JD, Dowlatshahi K. Ackland SP, et al. Surg Gynecol Obstet. 1985 Oct;161(4):399-408. Surg Gynecol Obstet. 1985. PMID: 3901356 Review.

5

Dose-intensive epirubicin-based chemotherapy is superior to an intensive intravenous cyclophosphamide, methotrexate, and fluorouracil regimen in metastatic breast cancer: a randomized multinational study.

Ackland SP, Anton A, Breitbach GP, Colajori E, Tursi JM, Delfino C, Efremidis A, Ezzat A, Fittipaldo A, Kolaric K, Lopez M, Viaro D; HEPI 013 study group. Ackland SP, et al. J Clin Oncol. 2001 Feb 15;19(4):943-53. doi: 10.1200/JCO.2001.19.4.943. J Clin Oncol. 2001. PMID: 11181656 Clinical Trial.

6

Factors affecting epirubicin pharmacokinetics and toxicity: evidence against using body-surface area for dose calculation.

Gurney HP, Ackland S, Gebski V, Farrell G. Gurney HP, et al. J Clin Oncol. 1998 Jul;16(7):2299-304. doi: 10.1200/JCO.1998.16.7.2299. J Clin Oncol. 1998. PMID: 9667243

7

Application of liquid chromatography-mass spectrometry to monitoring plasma cyclophosphamide levels in phase I trial cancer patients.

Liu JJ, Kestell P, Findlay M, Riley G, Ackland S, Simpson A, Isaacs R, McKeage MJ. Liu JJ, et al. Clin Exp Pharmacol Physiol. 2004 Oct;31(10):677-82. doi: 10.1111/j.1440-1681.2004.03065.x. Clin Exp Pharmacol Physiol. 2004. PMID: 15554907 Clinical Trial.

8

Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer.

Wong M, Balleine RL, Blair EY, McLachlan AJ, Ackland SP, Garg MB, Evans S, Farlow D, Collins M, Rivory LP, Hoskins JM, Mann GJ, Clarke CL, Gurney H. Wong M, et al. Among authors: ackland sp. J Clin Oncol. 2006 Jun 1;24(16):2448-55. doi: 10.1200/JCO.2005.02.1295. Epub 2006 May 1. J Clin Oncol. 2006. PMID: 16651648

9

Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer.

Bishop JF, Dewar J, Toner GC, Smith J, Tattersall MH, Olver IN, Ackland S, Kennedy I, Goldstein D, Gurney H, Walpole E, Levi J, Stephenson J, Canetta R. Bishop JF, et al. J Clin Oncol. 1999 Aug;17(8):2355-64. doi: 10.1200/JCO.1999.17.8.2355. J Clin Oncol. 1999. PMID: 10561297 Clinical Trial.

10

Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancer.

Stockler MR, Harvey VJ, Francis PA, Byrne MJ, Ackland SP, Fitzharris B, Van Hazel G, Wilcken NR, Grimison PS, Nowak AK, Gainford MC, Fong A, Paksec L, Sourjina T, Zannino D, Gebski V, Simes RJ, Forbes JF, Coates AS. Stockler MR, et al. Among authors: ackland sp. J Clin Oncol. 2011 Dec 1;29(34):4498-504. doi: 10.1200/JCO.2010.33.9101. Epub 2011 Oct 24. J Clin Oncol. 2011. PMID: 22025143 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters